Macrogenics (MGNX) Accounts Payables (2012 - 2026)
Macrogenics' (MGNX) quarterly Accounts Payables came in at $4.3 million in Q1 2026, down 35.21% year-on-year from $6.6 million in Q1 2025, and down 10.44% on a QoQ basis from $4.8 million in Q4 2025.
Macrogenics (MGNX) Accounts Payables (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Accounts Payables data on file, last reported at $4.3 million in Q1 2026.
- On a quarterly basis, Accounts Payables fell 35.21% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 35.21% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 4.51% from the prior year.
- Accounts Payables for Q1 2026 stood at $4.3 million, down from $4.8 million in the prior quarter.
- Over the last five years, Accounts Payables for MGNX reached as high as $10.7 million in Q1 2024 and fell as low as $2.6 million in Q2 2022.
- Historically, Accounts Payables has averaged $5.1 million across 5 years, with a median of $4.8 million in 2025.
- Across the five-year window, Accounts Payables sank 73.43% in 2022 and surged 184.49% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $4.9 million in 2022, then jumped by 31.52% to $6.4 million in 2023, then dropped by 22.19% to $5.0 million in 2024, then slipped by 4.51% to $4.8 million in 2025, then declined by 10.44% to $4.3 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $4.3 million in Q1 2026, $4.8 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 4.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.29 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 5.94 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 6.62 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 5.24 Mn |
| Mar 31, 2024 | 10.69 Mn |
| Dec 31, 2023 | 6.44 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 3.76 Mn |
| Dec 31, 2022 | 4.90 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 2.61 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 15.50 Mn |
| Sep 30, 2021 | 6.17 Mn |
| Jun 30, 2021 | 9.82 Mn |